190 related articles for article (PubMed ID: 11907465)
1. Advances in gene therapy for malignant melanoma.
Sotomayor MG; Yu H; Antonia S; Sotomayor EM; Pardoll DM
Cancer Control; 2002; 9(1):39-48. PubMed ID: 11907465
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma.
Califano J; Nance M
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
[TBL] [Abstract][Full Text] [Related]
3. Vaccines for melanoma.
Bystryn JC
Dermatol Clin; 2002 Oct; 20(4):717-25. PubMed ID: 12380059
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for melanoma.
Kim CJ; Dessureault S; Gabrilovich D; Reintgen DS; Slingluff CL
Cancer Control; 2002; 9(1):22-30. PubMed ID: 11907463
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for the management of advanced melanoma: the next steps.
Zikich D; Schachter J; Besser MJ
Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
[TBL] [Abstract][Full Text] [Related]
6. [Interferon therapy in malignant melanoma].
Kokoschka EM; Micksche M
Wien Med Wochenschr; 1993; 143(16-17):441-2. PubMed ID: 8273369
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant and palliative therapy of melanoma. Current status].
Tilgen W
Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma and the sentinel lymph node biopsy.
Kuhn JA; McCarty TM
Cancer Invest; 1999; 17(1):39-46. PubMed ID: 10999048
[No Abstract] [Full Text] [Related]
9. Melanoma: is immunotherapy of benefit?
Faries MB; Morton DL
Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
[No Abstract] [Full Text] [Related]
10. Childhood melanoma.
Jen M; Murphy M; Grant-Kels JM
Clin Dermatol; 2009; 27(6):529-36. PubMed ID: 19880040
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors and improving treatment of cutaneous melanoma].
Vihinen P; Kähäri VM; Pyrhönen S
Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
[No Abstract] [Full Text] [Related]
12. Cutaneous melanoma: detecting it earlier, weighing management options.
Lane JE; Dalton RR; Sangueza OP
J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
[No Abstract] [Full Text] [Related]
13. Determinants of unfavorable presentation of primary cutaneous melanoma.
Fallah M; Kharazmi E; Thomsen H; Sundquist J; Hemminki K
J Am Acad Dermatol; 2011 Jul; 65(1):e5-6. PubMed ID: 21679807
[No Abstract] [Full Text] [Related]
14. Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome.
Ridolfi L; Petrini M; Fiammenghi L; Granato AM; Ancarani V; Pancisi E; Brolli C; Selva M; Scarpi E; Valmorri L; Nicoletti SV; Guidoboni M; Riccobon A; Ridolfi R
Melanoma Res; 2011 Dec; 21(6):524-9. PubMed ID: 21909041
[TBL] [Abstract][Full Text] [Related]
15. Spanish Multidisciplinary Melanoma Group (GEM) guidelines for the management of patients with advanced melanoma.
Berrocal A; Espinosa E; Marín S; Malvehy J; Moreno D; Lozano MD; Martin-Algarra S; Lopez JA; Conill C; Rodriguez-Peralto JL
Eur J Dermatol; 2015; 25(5):392-403. PubMed ID: 26693633
[TBL] [Abstract][Full Text] [Related]
16. [The adjuvant therapy of malignant melanoma].
Hauschild A; Sterry W
Dtsch Med Wochenschr; 1992 Feb; 117(8):303-6. PubMed ID: 1537268
[No Abstract] [Full Text] [Related]
17. Unusual variants of malignant melanoma.
Barnhill RL; Gupta K
Clin Dermatol; 2009; 27(6):564-87. PubMed ID: 19880044
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with localized primary cutaneous melanoma.
Mervic L
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
